What stage does Klein & Partners AG invest at?

Klein & Partners AG invests at the Growth, Late Stage stages.

What is Klein & Partners AG's typical check size?

Klein & Partners AG typically writes checks of $550K – $5.5M.

What sectors does Klein & Partners AG focus on?

Klein & Partners AG focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.

Where is Klein & Partners AG located?

Klein & Partners AG is headquartered in Zug, CH.

Klein & Partners AG

Family office

Zug · Growth–Late Stage · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Klein & Partners AG

✨ Fox Verdict

Investment thesis

Klein & Partners AG invests its own capital directly into private market opportunities across equity and credit, favoring special situations where speed, discretion and entrepreneurial judgment matter. It supports entrepreneurs and owners with bridge loans, warehousing facilities, shareholder liquidity, secondary transactions, acquisition and growth financing. Rather than committing to funds or blind pools, it takes direct exposure to companies or specific assets through flexible structures spanning equity, shareholder loans and secured credit. Typical initial tickets run from EUR 0.5 million to EUR 5 million, with capacity for larger deals alongside trusted co-investors. The firm positions itself as a long-term, aligned partner contributing capital, transaction experience and network to create value and provide scarce liquidity.

Invests inBiotech Healthtech Medical DevicesSector AgnosticEurope Switzerland Zug

Source: firm website, verified Aug 3, 2026.

Stage

Growth–Late Stage

Check

$550K – $5.5M

Zug, CH

Instruments

Equity · Debt

Team · 2 people

from the firm's website

Daniel Klein

A hands-on direct investor and entrepreneur with over 15 years of experience across private equity, private credit, M&A, strategy and value creation. Co-founder of LUCID Partners, formerly a Single Family Office Managing Director and Bain & Company consultant; holds an INSEAD MBA and an LSE MSc.

Sarah Klein· Dr.

Brings over a decade of international leadership across healthcare, commercial strategy and business transformation, with senior roles at Bristol Myers Squibb and Johnson & Johnson. Focuses on company building and healthcare innovation; holds an MSc from Imperial College London and a Dr. sc. from ETH Zurich.

Frequently asked questions

What stage does Klein & Partners AG invest at?: Klein & Partners AG invests at the Growth, Late Stage stages.
What is Klein & Partners AG's typical check size?: Klein & Partners AG typically writes checks of $550K – $5.5M.
What sectors does Klein & Partners AG focus on?: Klein & Partners AG focuses on Biotech, Healthtech, Medical Devices, Sector Agnostic.
Where is Klein & Partners AG located?: Klein & Partners AG is headquartered in Zug, CH.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

Kreos Capital

Kreos Capital is a growth debt provider founded in 1998, financing high-growth technology and healthcare companies across Europe and Israel. It was acquired by BlackRock in August 2023 and operates its Growth Debt strategy within BlackRock's Private Markets platform.